NEW YORK (GenomeWeb) —Institute for Systems Biology spinout Arivale plans to provide customers with personalized health recommendations based on a variety of molecular and lifestyle datasets, including their genome sequence.

The company, co-founded in early 2014 by ISB President Lee Hood, CEO Clayton Lewis, and ISB Associate Director Nathan Price, said today that it raised $36 million in a Series B funding round that was led by venture firms Arch Venture Partners and Polaris Partners. Maveron, which led Arivale's $3 million Series A round, also participated in the latest round.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Germany's Project DEAL has come to an agreement with the publisher Wiley over journal access and open-access publishing, ScienceInsider reports.

A Canadian panel recommends public coverage of the gene therapy Kymriah if its cost comes down, the Globe and Mail reports.

Researchers uncover additional loci associated with lifespan, which the Telegraph says could be folded into a genetic test.

In Nucleic Acids Research this week: new accurate quantification by sequencing approach, CNV breakpoints in Plasmodium falciparum, and more.